{
  "id": 6262325,
  "title": "Tinubu’s drug allegation: ‘Stop the lies’ — Fani-Kayode blasts US lobbyist firm",
  "url": "https://urgent.news/2026/09/08/tinubus-drug-allegation-stop-the-lies-fani-kayode-blasts-us-lobbyist",
  "topic": "world",
  "section": "World",
  "published": "2026-09-08T09:03:46.000Z",
  "source": {
    "name": "Daily Post Nigeria",
    "slug": "daily-post-nigeria",
    "url": "https://dailypost.ng/2026/09/08/tinubus-drug-allegation-stop-the-lies-fani-kayode-blasts-us-lobbyist-firm/"
  },
  "original_language": "en",
  "account": "Nigeria's High Commissioner to South Africa, Femi Fani-Kayode, has strongly criticised US-based lobbying firm Von Batten-Montague-York for allegations against President Bola Tinubu. In a statement on X, Fani-Kayode accused the firm and its managing partner, Karl Ikemefuna Von Batten, of disseminating false and misleading information about the Nigerian president. Fani-Kayode claimed his email and social media messages had been inundated with materials related to Tinubu, which he said originated from Von Batten and his firm. Forbes reports that Von Batten-Montague-York has recently raised concerns over old US court proceedings involving Tinubu, engaging American officials over related documents. However, Fani-Kayode dismissed the allegations as attempts to tarnish Tinubu's reputation and rejected claims that Von Batten was offered $3 million to end his campaign against the president.",
  "summary": "Nigeria’s High Commissioner to South Africa, Femi Fani-Kayode, has blasted United States-based lobbying firm Von Batten-Montague-York, L.C., over what he described as its campaign against President Bola Tinubu. In a statement posted on his verified X handle on Tuesday, Fani-Kayode accused the firm and its managing partner, Karl Ikemefuna Von Batten, of spreading what he […] Tinubu’s drug…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}